Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of HLA-A mRNA | decreases expression | 19128835
|
C020711 |
beryllium sulfate |
beryllium sulfate results in increased expression of HLA-A mRNA | increases expression | 16314022
|
D002220 |
Carbamazepine |
HLA-A gene SNP affects the susceptibility to Carbamazepine | affects response to substance | 16538176
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of HLA-A mRNA | increases expression | 15963578
|
D002945 |
Cisplatin |
HLA-A protein affects the susceptibility to Cisplatin | affects response to substance | 16217747
|
D004391 |
Dust |
Dust results in increased expression of HLA-A mRNA | increases expression | 17805423
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of HLA-A mRNA | affects cotreatment|decreases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased expression of HLA-A mRNA | increases expression | 19619570
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of HLA-A mRNA | affects cotreatment|increases expression | 17183730
|
D008727 |
Methotrexate |
HLA-A protein affects the susceptibility to Methotrexate | affects response to substance | 16217747
|
C030984 |
pyrene |
pyrene results in decreased expression of HLA-A mRNA | decreases expression | 15963578
|
D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of HLA-A mRNA | increases expression | 18175754
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of HLA-A mRNA | affects cotreatment|decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of HLA-A mRNA | decreases expression | 19619570
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of HLA-A mRNA | affects cotreatment|increases expression | 17183730
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of HLA-A mRNA | increases expression | 19101580
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Carbamazepine |
21.46 | 8986270 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
21.46 | 12039119 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
21.46 | 14514962 15322242 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
21.46 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.01 | 19490988 |
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
4.04 | 12690470 15814532 17670903 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
7.28 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
7.28 | 11798837 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
7.28 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.49 | 16835633 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.37 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.02 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.64 | 17497229 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
3.11 | 17286800 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 16720216 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.00 | 17157402 18985861 18396377 20603192 18775368 18316065 19460635 18558336 16609825 15238991 19232924 17507914 18177632 18940202 17688650 |
MESH:D001714 |
Bipolar Disorder |
|
Carbamazepine |
7.68 | 17594078 20046352 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
7.68 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
9.23 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.23 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.92 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
8.19 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
8.19 | 8888407 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
5.02 | 14601052 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
2.01 | 18382427 19526202 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.01 | 19861407 17289903 14630087 12948864 18497071 17261762 16675129 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
2.01 | 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.01 | 20435547 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.42 | 11589617 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.58 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.88 | 16050911 16011737 15700767 15673190 18705752 15721981 16192424 16227642 16124888 16097048 3786805 10355542 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.86 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
6.71 | 16217749 11135700 14691202 15553829 15073043 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
6.71 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
6.71 | 17982673 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
6.71 | 16924424 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
3.06 | 16685392 12023789 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
5.01 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.19 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
2.84 | 18337622 17066447 6189445 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.41 | 18850075 18670907 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
2.82 | 18566989 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.73 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.23 | 16835633 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.86 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.13 | 16354765 12621046 15668235 8697196 15340226 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
2.68 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
2.68 | 15273666 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.13 | 14669216 17141729 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.28 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
7.46 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Carbamazepine |
7.46 | 9014606 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
7.46 | 12039119 9562676 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
7.46 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
7.46 | 8888407 16575769 17688650 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
4.31 | 19747007 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.18 | 15213294 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
5.22 | 20191521 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.85 | 16285004 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.68 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.48 | 19279558 |
OMIM:607208 |
DRAVET SYNDROME |
|
Carbamazepine |
5.55 | 11748493 |
MESH:D004342 |
Drug Hypersensitivity |
|
Carbamazepine |
4.45 | 16538176 16538175 15057820 20216337 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbamazepine |
12.29 | 17465707 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
12.29 | 19085960 6884620 15968718 10092053 2869522 15027814 16177239 7179309 9327722 7120509 21278145 11566570 16227642 19336974 4309450 6623471 17522070 3732212 7440962 3786805 10915739 15998439 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
12.29 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
12.29 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
12.29 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Carbamazepine |
14.24 | 20216337 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
14.24 | 19839026 12649298 15033597 12231392 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
14.24 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.14 | 1851702 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.46 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.04 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Carbamazepine |
4.83 | 17654737 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
3.03 | 19148513 11473722 18566989 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.10 | 10568697 9294722 |
MESH:D004816 |
Epidermal Necrolysis, Toxic |
|
Carbamazepine |
5.35 | 19915237 16538176 18855540 20485159 16415921 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Carbamazepine |
11.55 | 17275665 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
11.55 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Carbamazepine |
10.83 | 16628512 17116037 15008574 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
10.83 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Carbamazepine |
7.20 | 17178248 9014606 19620853 20417680 19700373 821787 7988514 17465707 18234410 19439326 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
7.20 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.66 | 6426943 6254150 7562514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Carbamazepine |
12.06 | 7750514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
12.06 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Carbamazepine |
11.28 | 15276670 3659116 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
11.28 | 3659116 |
MESH:D004916 |
Erythromelalgia |
|
Carbamazepine |
5.84 | 19549232 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
4.78 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
4.78 | 15173087 16785472 15464296 17638652 16481741 |
MESH:D005076 |
Exanthema |
|
Carbamazepine |
5.58 | 20485159 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.07 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
13.66 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
13.66 | 15959796 16045604 12631006 17595544 12795759 19224547 16239168 61145 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
13.66 | 19224547 14986274 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.56 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.02 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.23 | 8888407 18558336 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
8.95 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.95 | 20067830 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.36 | 16904648 |
MESH:D005910 |
Glioma |
marker/mechanism |
|
| 14511464 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.73 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
5.25 | 16518429 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
3.77 | 15464296 15102660 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
4.37 | 19898482 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
4.49 | 15464296 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.37 | 10048152 11294989 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.42 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.69 | 19900420 19110552 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.00 | 15340226 16120746 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.17 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
3.66 | 16200630 16170182 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.89 | 17088409 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.98 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.18 | 8697196 16959395 15340226 18606429 16354765 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.65 | 16899240 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Carbamazepine |
4.80 | 10459572 |
MESH:D006965 |
Hyperplasia |
|
Carbamazepine |
5.31 | 18773962 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.93 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.19 | 15338365 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.73 | 16612254 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.89 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.61 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
7.61 | 14714311 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.42 | 16580747 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
5.27 | 15464296 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
6.42 | 19839026 12649298 12231392 18289764 15190930 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
6.42 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
3.05 | 15610895 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
4.93 | 11231351 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
5.19 | 9562676 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
2.87 | 15070760 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.88 | 12560223 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.42 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.49 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.84 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
3.95 | 16467208 17050201 20471514 16968895 19850784 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.95 | 17596541 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
3.26 | 12712474 16331271 16891316 17869043 16112521 11161223 19075265 16966277 15213294 12679006 17649720 16330433 19642359 19225113 16823087 17217047 17107899 12018890 11468182 15748426 17712046 15622746 9834237 15336539 19035177 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.45 | 16882451 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
7.07 | 17157831 16943688 16221502 11408273 21278145 16239168 17174718 17334410 11903743 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
7.07 | 14986274 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
3.48 | 17525996 12546737 18187930 15931870 16033810 17708605 18418968 15730626 16097048 15338365 15996030 17869086 13678700 18251166 17900296 15818738 18205269 17714472 12741479 12389079 15893842 15925388 18279442 15370692 17721639 16248980 18263696 14748882 10355542 17698563 15650968 14716496 15052691 15123356 15959796 17823541 17631135 17761835 12586293 16638106 17565644 18412020 18156304 12898905 18429990 18376398 15362042 17557913 18317297 18054572 12958196 16136751 18339082 17922224 17976157 18210741 12632512 18472094 16027843 12666154 16011737 18006644 16116963 17805973 15876570 12649538 17640975 14620537 12445421 15673190 16192424 14512876 12667390 12632514 18166357 17481882 15057751 18472332 14716833 18395914 12445418 17766677 11481614 18277467 17944888 20821823 16015684 18481824 18420326 12609069 18395095 14724832 18705752 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.48 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.48 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
2.10 | 17285989 16964402 15720792 16246199 15830285 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.27 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.77 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
7.57 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
7.57 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.57 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
10.10 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
10.10 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
10.10 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.41 | 15213294 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
11.92 | 18516814 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
11.92 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
3.51 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
3.51 | 11798837 6189445 17225452 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.51 | 11884234 19555203 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Carbamazepine |
3.59 | 16628512 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
4.01 | 17352296 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.15 | 14737004 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
2.61 | 16891317 11408345 17203775 11807958 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.62 | 19453300 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
2.48 | 12374674 17023156 18332650 16809738 18176117 15577323 12393984 16432458 11135225 18505091 12883367 16248763 17761969 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
4.89 | 15990972 |
MESH:D008607 |
Mental Retardation |
|
Carbamazepine |
3.75 | 9014606 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
3.27 | 17638057 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.25 | 18765137 18803445 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
5.40 | 17488658 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.16 | 19417148 11468182 19549372 14977855 15949261 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.11 | 8888407 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.81 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
7.56 | 16105982 16882451 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
7.56 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.08 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.34 | 16810080 |
MESH:D009224 |
Myotonia Congenita |
|
Carbamazepine |
5.58 | 20399394 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
4.05 | 16624393 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
2.97 | 16773208 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.85 | 17289903 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
4.63 | 15464296 |
MESH:D009421 |
Nervous System Malformations |
|
Carbamazepine |
17.06 | 16990009 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
17.06 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
17.06 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
7.50 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
7.50 | 8888407 16359493 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
3.49 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
4.81 | 8761367 |
MESH:D010018 |
Osteomalacia |
|
Carbamazepine |
5.58 | 17016548 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
8.08 | 12452020 19769630 16624393 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
8.08 | 15464296 19769630 17225452 6897625 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
8.08 | 19401270 |
MESH:D010146 |
Pain |
|
Carbamazepine |
4.10 | 15215642 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
5.57 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
5.57 | 19003803 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.25 | 19927285 |
MESH:D010267 |
Parapsoriasis |
marker/mechanism |
|
| 16538176 |
MESH:D010267 |
Parapsoriasis |
|
Carbamazepine |
5.80 | 16538176 |
OMIM:167400 |
PAROXYSMAL EXTREME PAIN DISORDER |
|
Carbamazepine |
6.04 | 17145499 17679678 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.38 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
4.40 | 15464296 |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
5.48 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.65 | 18163543 |
MESH:D011248 |
Pregnancy Complications |
|
Carbamazepine |
5.26 | 9014606 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Carbamazepine |
17.09 | 9014606 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
17.09 | 11222880 11896295 11118676 11399792 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
17.09 | 20603192 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.97 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.56 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.56 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
2.56 | 18760546 |
MESH:D019310 |
Pseudolymphoma |
|
Carbamazepine |
13.05 | 9591791 12752131 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
13.05 | 12752131 11422049 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
3.46 | 17410198 |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
10.91 | 15464296 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
10.91 | 17352296 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.93 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.26 | 19155313 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
10.67 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
10.67 | 14601052 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.08 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Carbamazepine |
6.59 | 16876388 16938433 9844417 16180713 9046859 15946322 19414003 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
6.59 | 1511512 17978042 14763951 15475178 11044598 11738929 3137016 16876388 |
OMIM:608579 |
SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO |
marker/mechanism |
|
| |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.08 | 16192470 |
MESH:D012893 |
Sleep Disorders |
|
Carbamazepine |
5.24 | 19414003 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
5.48 | 15464296 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.84 | 19490988 |
OMIM:106300 |
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1 |
marker/mechanism |
|
| |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.67 | 12833885 |
MESH:D013262 |
Stevens-Johnson Syndrome |
|
Carbamazepine |
5.31 | 19694795 15057820 16538176 18855540 19915237 16415921 20485159 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
2.67 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
2.67 | 15958060 18396642 17522103 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
5.13 | 9562676 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
4.72 | 17225452 15464296 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.04 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
3.15 | 19014326 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.82 | 19048282 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
4.08 | 15213294 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.37 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.64 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
5.42 | 11780464 20435036 12973940 12845720 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
5.42 | 15464296 12973940 17225452 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.75 | 8888407 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
4.28 | 16803524 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
4.71 | 15577323 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.73 | 12125929 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
4.85 | 11897121 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.38 | 15886252 |